The objective of this study is to evaluate whether the IOP lowering with Rocklatan® is
similar, or demonstrates additional IOP lowering, in subjects on a current regimen of
latanoprost alone or latanoprost plus addition of either one or two individual agents/bottles
with another mechanism of action.